{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:51:07Z","timestamp":1788576667420,"version":"build-2803163510"},"reference-count":77,"publisher":"BMJ","issue":"1","funder":[{"name":"Vietnam International Education Development"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2017,11,10]]},"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Ischaemic heart diseases (IHDs) are a leading cause of death worldwide. Although prescribing according to guidelines improves health outcomes, it remains suboptimal. We determined whether interventions targeted at healthcare professionals are effective to enhance prescribing and health outcomes in patients with IHDs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We systematically searched PubMed and EMBASE for studies published between 1 January 2000 and 31 August 2017. We included original studies of interventions targeted at healthcare professionals to enhance prescribing guideline-recommended medications for IHDs. We only included randomised controlled trials (RCTs). Main outcomes were the proportion of eligible patients receiving guideline-recommended medications, the proportion of patients achieving target blood pressure and target low-density lipoprotein-cholesterol (LDL-C)\/cholesterol level and mortality rate. Meta-analyses were performed using the inverse-variance method and the random effects model. The quality of evidence was assessed using the Grading of Recommendations, Assessment, Development, and Evaluation approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 13 studies, 4 RCTs (1869 patients) and 9 cluster RCTs (15\u2009224 patients). 11 out of 13 studies were performed in North America and Europe. Interventions were of organisational or professional nature. The interventions significantly enhanced prescribing of statins\/lipid-lowering agents (OR 1.23; 95%\u2009CI 1.07 to 1.42, P=0.004), but not other medications (aspirin\/antiplatelet agents, beta-blockers, ACE inhibitors\/angiotensin II receptor blockers and the composite of medications). There was no significant association between the interventions and improved health outcomes (target LDL-C and mortality) except for target blood pressure (OR 1.46; 95%\u2009CI 1.11 to 1.93; P=0.008). The evidence was of moderate or high quality for all outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Organisational and professional interventions improved prescribing of statins\/lipid-lowering agents and target blood pressure in patients with IHDs but there was little evidence of change in other outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"CRD42016039188\">CRD42016039188<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2017-018271","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T01:31:58Z","timestamp":1515634318000},"page":"e018271","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Enhancing prescribing of guideline-recommended medications for ischaemic heart diseases: a systematic review and meta-analysis of interventions targeted at healthcare professionals"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7799-4523","authenticated-orcid":false,"given":"Thang","family":"Nguyen","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Can Tho University of Medicine and Pharmacy, Can Tho, Vietnam"},{"name":"Groningen Research Institute of Pharmacy, Unit of PharmacoTherapy, Epidemiology & Economics, University of Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoa Q","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, University of Medicine and Pharmacy, Ho Chi Minh, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niken N","family":"Widyakusuma","sequence":"additional","affiliation":[{"name":"Division of Management and Community Pharmacy, Faculty of Pharmacy, Gadjah Mada University, Yogyakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thao H","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, University of Medicine and Pharmacy, Ho Chi Minh, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam T","family":"Pham","sequence":"additional","affiliation":[{"name":"Faculty of Public Health, Can Tho University of Medicine and Pharmacy, Can Tho, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Taxis","sequence":"additional","affiliation":[{"name":"Groningen Research Institute of Pharmacy, Unit of PharmacoTherapy, Epidemiology & Economics, University of Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,1,10]]},"reference":[{"key":"2025121601551011000_8.1.e018271.1","unstructured":"World Health Organization. The top 10 causes of death, 2017."},{"key":"2025121601551011000_8.1.e018271.2","unstructured":"World Health Organization. International statistical classification of diseases and related health problems 10th revision (ICD-10)-WHO Version for 2016, 2016."},{"key":"2025121601551011000_8.1.e018271.3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs215"},{"key":"2025121601551011000_8.1.e018271.4","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3182742cf6"},{"key":"2025121601551011000_8.1.e018271.5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht296"},{"key":"2025121601551011000_8.1.e018271.6","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000134"},{"key":"2025121601551011000_8.1.e018271.7","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e318277d6a0"},{"key":"2025121601551011000_8.1.e018271.8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv320"},{"key":"2025121601551011000_8.1.e018271.9","first-page":"28","article-title":"Adherence to clinical practice guidelines for 7 chronic conditions in long-term-care patients who received pharmacist disease management services versus traditional drug regimen review","volume":"13","author":"Horning","year":"2007","journal-title":"J Manag Care Pharm"},{"key":"2025121601551011000_8.1.e018271.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2011.04.025"},{"key":"2025121601551011000_8.1.e018271.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.10.063"},{"key":"2025121601551011000_8.1.e018271.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.12.083"},{"key":"2025121601551011000_8.1.e018271.13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.580"},{"key":"2025121601551011000_8.1.e018271.14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.2.180"},{"key":"2025121601551011000_8.1.e018271.15","first-page":"271","article-title":"Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge","volume":"14","author":"Lee","year":"2008","journal-title":"J Manag Care Pharm"},{"key":"2025121601551011000_8.1.e018271.16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.505636"},{"key":"2025121601551011000_8.1.e018271.17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1573403X12666160504100025","article-title":"Adherence to cardiac practice guidelines in the management of non-st-elevation acute coronary syndromes: a systematic literature review","volume":"13","author":"Engel","year":"2017","journal-title":"Curr Cardiol Rev"},{"key":"2025121601551011000_8.1.e018271.18","doi-asserted-by":"crossref","unstructured":"Forsetlund L , Bj\u00f8rndal A , Rashidian A , et al . Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2009;(2):CD003030.doi:10.1002\/14651858.CD003030.pub2","DOI":"10.1002\/14651858.CD003030.pub2"},{"key":"2025121601551011000_8.1.e018271.19","article-title":"Printed educational materials: effects on professional practice and healthcare outcomes","volume":"10","author":"Gigu\u00e8re","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121601551011000_8.1.e018271.20","article-title":"Educational outreach visits: effects on professional practice and health care outcomes","volume":"17","author":"O\u2019Brien","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121601551011000_8.1.e018271.21","doi-asserted-by":"crossref","unstructured":"Reeves S , Perrier L , Goldman J , et al . Interprofessional education: effects on professional practice and healthcare outcomes (update). Cochrane Database Syst Rev 2013;(3):CD002213.doi:10.1002\/14651858.CD002213.pub3","DOI":"10.1002\/14651858.CD002213.pub3"},{"key":"2025121601551011000_8.1.e018271.22","first-page":"CD001175","article-title":"Computer-generated reminders delivered on paper to healthcare professionals; effects on professional practice and health care outcomes","volume":"12","author":"Arditi","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121601551011000_8.1.e018271.23","doi-asserted-by":"crossref","unstructured":"Ivers N , Jamtvedt G , Flottorp S , et al . Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev 2012:CD000259.doi:10.1002\/14651858.CD000259.pub3","DOI":"10.1002\/14651858.CD000259.pub3"},{"key":"2025121601551011000_8.1.e018271.24","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-10-2"},{"key":"2025121601551011000_8.1.e018271.25","doi-asserted-by":"crossref","unstructured":"Nkansah N , Mostovetsky O , Yu C , et al . Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev 2010;(7):CD000336.doi:10.1002\/14651858.CD000336.pub2","DOI":"10.1002\/14651858.CD000336.pub2"},{"key":"2025121601551011000_8.1.e018271.26","doi-asserted-by":"crossref","unstructured":"Rashidian A , Omidvari AH , Vali Y , et al . Pharmaceutical policies: effects of financial incentives for prescribers. Cochrane Database Syst Rev 2015;(8):CD006731.doi:10.1002\/14651858.CD006731.pub2","DOI":"10.1002\/14651858.CD006731.pub2"},{"key":"2025121601551011000_8.1.e018271.27","doi-asserted-by":"crossref","unstructured":"Luiza VL , Chaves LA , Silva RM , et al . Pharmaceutical policies: effects of cap and co-payment on rational use of medicines. Cochrane Database Syst Rev 2015;(5):CD007017.doi:10.1002\/14651858.CD007017.pub2","DOI":"10.1002\/14651858.CD007017.pub2"},{"key":"2025121601551011000_8.1.e018271.28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12875-015-0341-7","article-title":"Interventions to improve adherence to cardiovascular disease guidelines: a systematic review","volume":"16","author":"Jeffery","year":"2015","journal-title":"BMC Fam Pract"},{"key":"2025121601551011000_8.1.e018271.29","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmt080"},{"key":"2025121601551011000_8.1.e018271.30","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp15X685681"},{"key":"2025121601551011000_8.1.e018271.31","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-8-35"},{"key":"2025121601551011000_8.1.e018271.32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700"},{"key":"2025121601551011000_8.1.e018271.33","unstructured":"In: Higgins JPT , Green S , eds. Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration, 2016. Updated Mar 2011."},{"key":"2025121601551011000_8.1.e018271.34","unstructured":"Nguyen T , Widyakusuma NN , Nguyen HQ , et al . Interventions to enhance prescribing guideline-recommended medications for patients with ischemic heart diseases: a systematic review and meta-analysis. PROSPERO 2016:CRD42016039188."},{"key":"2025121601551011000_8.1.e018271.35","unstructured":"Effective Practice and Organisation of Care (EPOC). Suggested risk of bias criteria for EPOC reviews. EPOC Resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services, 2015:2016."},{"key":"2025121601551011000_8.1.e018271.36","unstructured":"Effective Practice and Organisation of Care (EPOC). Type of intervention. EPOC resources for review authors. oslo: Norwegian knowledge centre for the health services, 2016."},{"key":"2025121601551011000_8.1.e018271.37","unstructured":"The Cochrane Collaboration. Review manager (revman) [computer program]. Version 5.3. 2014."},{"key":"2025121601551011000_8.1.e018271.38","doi-asserted-by":"publisher","DOI":"10.1177\/096228020101000502"},{"key":"2025121601551011000_8.1.e018271.39","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1301"},{"key":"2025121601551011000_8.1.e018271.40","unstructured":"Sch\u00fcnemann H , Bro\u017cek J , Guyatt G , Oxman A , eds. Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. 2016, 2013."},{"key":"2025121601551011000_8.1.e018271.41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"2025121601551011000_8.1.e018271.42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"2025121601551011000_8.1.e018271.43","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.413"},{"key":"2025121601551011000_8.1.e018271.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2012.02.004"},{"key":"2025121601551011000_8.1.e018271.45","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cml075"},{"key":"2025121601551011000_8.1.e018271.46","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-11-5"},{"key":"2025121601551011000_8.1.e018271.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2011.07.027"},{"key":"2025121601551011000_8.1.e018271.48","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-6-105"},{"key":"2025121601551011000_8.1.e018271.49","first-page":"575","article-title":"A pharmacist-led follow-up program for patients with established coronary heart disease in North Norway - a randomized controlled trial","volume":"13","author":"Garcia","year":"2015","journal-title":"Pharm Pract"},{"key":"2025121601551011000_8.1.e018271.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.04.013"},{"key":"2025121601551011000_8.1.e018271.51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2753.2008.01066.x"},{"key":"2025121601551011000_8.1.e018271.52","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.106955"},{"key":"2025121601551011000_8.1.e018271.53","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.498"},{"key":"2025121601551011000_8.1.e018271.54","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-1-11"},{"key":"2025121601551011000_8.1.e018271.55","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.090917"},{"key":"2025121601551011000_8.1.e018271.56","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.322.7298.1338"},{"key":"2025121601551011000_8.1.e018271.57","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-141-7-200410050-00008"},{"key":"2025121601551011000_8.1.e018271.58","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmi090"},{"key":"2025121601551011000_8.1.e018271.59","doi-asserted-by":"publisher","DOI":"10.2310\/jim.0b013e3181620295"},{"key":"2025121601551011000_8.1.e018271.60","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2015-004372"},{"key":"2025121601551011000_8.1.e018271.61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.08.015"},{"key":"2025121601551011000_8.1.e018271.62","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hci006"},{"key":"2025121601551011000_8.1.e018271.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2011.10.128"},{"key":"2025121601551011000_8.1.e018271.64","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht295"},{"key":"2025121601551011000_8.1.e018271.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2013.03.020"},{"key":"2025121601551011000_8.1.e018271.66","doi-asserted-by":"publisher","DOI":"10.1177\/2047487312462824"},{"key":"2025121601551011000_8.1.e018271.67","doi-asserted-by":"publisher","DOI":"10.1586\/erc.12.20"},{"key":"2025121601551011000_8.1.e018271.68","doi-asserted-by":"publisher","DOI":"10.1191\/1740774505cn073oa"},{"key":"2025121601551011000_8.1.e018271.69","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.372"},{"key":"2025121601551011000_8.1.e018271.70","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ahj.2014.08.017","article-title":"Targeted versus standard feedback: results from a randomized quality improvement trial","volume":"169","author":"Lytle","year":"2015","journal-title":"Am Heart J"},{"key":"2025121601551011000_8.1.e018271.71","first-page":"ED000111","article-title":"Viewpoint: taking into account risks of random errors when analysing multiple outcomes in systematic reviews","volume":"3","author":"Jakobsen","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121601551011000_8.1.e018271.72","doi-asserted-by":"crossref","unstructured":"Flodgren G , Eccles MP , Shepperd S , et al . An overview of reviews evaluating the effectiveness of financial incentives in changing healthcare professional behaviours and patient outcomes. Cochrane Database Syst Rev 2011;(7):CD009255.doi:10.1002\/14651858.CD009255","DOI":"10.1002\/14651858.CD009255"},{"key":"2025121601551011000_8.1.e018271.73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003539.pub2"},{"key":"2025121601551011000_8.1.e018271.74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2016.02.009"},{"key":"2025121601551011000_8.1.e018271.75","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.15.1458"},{"key":"2025121601551011000_8.1.e018271.76","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2010.116012"},{"key":"2025121601551011000_8.1.e018271.77","doi-asserted-by":"publisher","DOI":"10.1111\/jep.12222"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2017-018271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T09:55:21Z","timestamp":1765878921000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-018271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,10]]},"published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1136\/bmjopen-2017-018271"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2017-018271","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}